T1	Participants 550 568	Patients in REFLEX
T2	Participants 428 540	patients with rheumatoid arthritis (RA) who had an inadequate response to tumor necrosis factor (TNF) inhibitors
T3	Participants 1243 1279	480 patients received â‰¥ 1 RTX course
